References
- Palmares J, Delgado L, Cidade M, Quadrado MJ, Filipe HP. Allergic conjunctivitis: A national cross-sectional study of clinical characteristics and quality of life. Eur J Ophthalmol. 2010;20(2):257–264. doi:https://doi.org/10.1177/112067211002000201.
- Leonardi A, Bogacka E, Fauquert JL, et al. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy. 2012;67(11):1327–1337. doi:https://doi.org/10.1111/all.12009.
- Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276–283. doi:https://doi.org/10.1016/j.jtos.2017.05.008.
- Leonardi A, De Dominicis C, Motterle L. Immunopathogenesis of ocular allergy: A schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol. 2007;7(5):429–435. doi:https://doi.org/10.1097/ACI.0b013e3282ef8674.
- Fujishima H, Toda I, Shimazaki J, Tsubota K. Allergic conjunctivitis and dry eye. Br J Ophthalmol. 1996;80(11):994–997. doi:https://doi.org/10.1136/bjo.80.11.994.
- Baudouin C. Formes frontières de l’allergie. J Fr Ophtalmol. 2007;30(3):306–313. doi:https://doi.org/10.1016/S0181-5512(07)89597-0.
- Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, et al. Conjunctival allergen provocation test: guidelines for daily practice. Allergy Eur J Allergy Clin Immunol. 2017;72(1):43–54. doi:https://doi.org/10.1111/all.12986.
- Hom MM, Nguyen AL, Bielory L. Allergic conjunctivitis and dry eye syndrome. Ann Allergy Asthma Immunol. 2012;108(3):163–166. doi:https://doi.org/10.1016/j.anai.2012.01.006.
- Chen L, Pi L, Fang J, Chen X, Ke N, Liu Q. High incidence of dry eye in young children with allergic conjunctivitis in Southwest China. Acta Ophthalmol. 2016;94(8):e727–e730. doi:https://doi.org/10.1111/aos.13093.
- Toda I, Shimazaki J, Tsubota K. Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology. 1995;102(2):302–309. doi:https://doi.org/10.1016/S0161-6420(95)31024-X.
- Berdy GJ, Hedqvist B. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management. Acta Ophthalmol Scand Suppl. 2000;78:32–37. doi:https://doi.org/10.1034/j.1600-0420.2000.078s230032.x.
- Villani E, Mantelli F, Nucci P. In-vivo confocal microscopy of the ocular surface: ocular allergy and dry eye. Curr Opin Allergy Clin Immunol. 2013;13(5):569–576. doi:https://doi.org/10.1097/ACI.0b013e328364ec92.
- Leonardi A, Lazzarini D, Bortolotti M, Piliego F, Midena E, Fregona I. Corneal confocal microscopy in patients with vernal keratoconjunctivitis. Ophthalmology. 2012;119(3):509–515. doi:https://doi.org/10.1016/j.ophtha.2011.09.018.
- Modugno RL, Scalora T, Bonaldo A, et al. Corneal microstructural changes by confocal microscopy in vernal keratoconjunctivitis patients treated with topical cyclosporine. Ocul Immunol Inflamm. 2020;00:1–7. doi:https://doi.org/10.1080/09273948.2020.1745243.
- Alhatem A, Cavalcanti BHP. In vivo confocal microscopy in dry eye disease and related conditions. Semin Ophthalmol. 2012;27:138–148.
- Gumus K, Cavanagh DH. The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. Clin Ophthalmol. 2009;3:57–67.
- Enríquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862–873.
- Wang S, Zhang H. Upregulation of the IL-33/ST2 pathway in dry eye. Mol Vis. 2019;25:583–592.
- Chen X, Deng R, Chi W, et al. IL-27 signaling deficiency develops Th17-enhanced Th2-dominant inflammation in murine allergic conjunctivitis model. Allergy. 2019;74:910–921. doi:https://doi.org/10.1111/all.13691.
- Chauan S, Dana R. Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunol. 2009;2(4):375–376. doi:https://doi.org/10.1038/mi.2009.21.
- Zhang X, Volpe EA, Gandhi NB, et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS One. 2012;7:1–10.
- Stern ME, Schaumburg CS, Dana R, Calonge M, Niederkorn JY, Pflugfelder SC. Autoimmunity at the ocular surface: pathogenesis and regulation. Mucosal Immunol. 2010;3:425–442.
- Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol. 2013;32:19–41.
- Suzuki S, Goto E, Dogru M, et al. Tear film lipid layer alterations in allergic conjunctivitis. Cornea. 2006;25(3):277–280. doi:https://doi.org/10.1097/01.ico.0000178277.29010.bc.
- Gipson IK, Argüeso P. Role of mucins in the function of the corneal and conjunctival epithelia. Int Rev Cytol. 2003;231:1–49.
- Jumblatt MM, McKenzie RW, Jumblatt JE. MUC5AC mucin is a component of the human precorneal tear film. Investig Ophthalmol Vis Sci. 1999;40:43–49.
- Zhang J, Yan X, Li H. Analysis of the correlations of mucins, inflammatory markers, and clinical tests in dry eye. Cornea. 2013;32(7):928–932. doi:https://doi.org/10.1097/ICO.0b013e3182801622.
- Dogru M, Asano-Kato N, Tanaka M, et al. Ocular Surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res. 2005;30(10):897–908. doi:https://doi.org/10.1080/02713680500196715.
- Dogru M, Matsumoto Y, Okada N, et al. Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis. Allergy Eur J Allergy Clin Immunol. 2008;63(10):1324–1334. doi:https://doi.org/10.1111/j.1398-9995.2008.01781.x.
- Portal C, Gouyer V, Gottrand F, Desseyn JL. Ocular mucins in dry eye disease. Exp Eye Res. 2019;186:107724. doi:https://doi.org/10.1016/j.exer.2019.107724.
- De Paiva CS, Villarreal AL, Corrales RM, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ. Investig Ophthalmol Vis Sci. 2007;48(6):2553–2560. doi:https://doi.org/10.1167/iovs.07-0069.
- Zhang X, Chen W, De Paiva CS, et al. Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Investig Ophthalmol Vis Sci. 2011;52(9):6279–6285. doi:https://doi.org/10.1167/iovs.10-7081.
- El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009;50(8):3802–3807. doi:https://doi.org/10.1167/iovs.08-2417.
- De Paiva CS, Raince JK, McClellan AJ, et al. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. 2011;4:397–408.
- Wakamatsu TH, Dogru M, Ayako I, et al. Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease. Mol Vis. 2010;16:2465–2475.
- Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol. 1999;162:6233–6237.
- García-Posadas L, Hodges RR, Diebold Y, Dartt DA. Context-dependent regulation of conjunctival goblet cell function by allergic mediators. Sci Rep. 2018;8(1):1–11. doi:https://doi.org/10.1038/s41598-018-30002-x.
- Bielory L. Role of antihistamines in ocular allergy. Am J Med. 2002;113(9):34–37. doi:https://doi.org/10.1016/S0002-9343(02)01435-3.
- Welch D, Abelson MB, Andover N. Ocular drying associated with oral antihistamine (Loratadine) in the normal population-an evaluation of exaggerated dose effect. Adv Exp Med Biol. 2002;506:1051–1055.
- Ousler GW, Wilcox KA, Gupta G, Abelson MB, Fink K. An evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochloride. Ann Allergy Asthma Immunol. 2004;93(5):460–464. doi:https://doi.org/10.1016/S1081-1206(10)61413-5.
- Dogru M, Özmen A, Ertürk H, Ö S, Karatas A. Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: an open-label study. Clin Ther. 2002;24(8):1309–1321. doi:https://doi.org/10.1016/S0149-2918(02)80035-2.
- Ousler GW, Workman DA, Torkildsen GL. An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. Clin Ther. 2007;29(4):611–616. doi:https://doi.org/10.1016/j.clinthera.2007.03.017.
- Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Investig Ophthalmol Vis Sci. 2011;52(4):1994–2005. doi:https://doi.org/10.1167/iovs.10-6997e.
- Arita R, Itoh K, Maeda S, et al. Meibomian gland duct distortion in patients with perennial allergic conjunctivitis. Cornea. 2010;29(8):858–860. doi:https://doi.org/10.1097/ICO.0b013e3181ca3668.
- Reyes NJ, Chen Y, Rose Mathew CM, et al. Gupta and DRS. Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice. Sci Transl Med. 2018;10:eaas9164.
- Hu Y, Matsumoto Y, Adan ES, et al. Corneal in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis. Ophthalmology. 2008;115(11):2004–2012. doi:https://doi.org/10.1016/j.ophtha.2008.05.010.
- Leonardi A, Brun P, Abatangelo G, Plebani M, Secchi AG. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Investig Ophthalmol Vis Sci. 2003;44(7):3052–3058. doi:https://doi.org/10.1167/iovs.02-0766.
- Baudouin C, Messmer EM, Aragona P, et al. Revisiting the vicious circle of dry eye disease: A focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol. 2016;100(3):300–306. doi:https://doi.org/10.1136/bjophthalmol-2015-307415.
- Tesón M, González-García MJ, López-Miguel A, et al. Influence of a controlled environment simulating an in-flight airplane cabin on dry eye disease. Investig Ophthalmol Vis Sci. 2013;54(3):2093–2099. doi:https://doi.org/10.1167/iovs.12-11361.
- Alex A, Edwards A, Daniel Hays J, et al. Factors predicting the ocular surface response to desiccating environmental stress. Investig Ophthalmol Vis Sci. 2013;54(5):3325–3332. doi:https://doi.org/10.1167/iovs.12-11322.
- López-Miguel A, Tesón M, Martín-Montañez V, et al. Dry eye exacerbation in patients exposed to desiccating stress under controlled environmental conditions. Am J Ophthalmol. 2014 Apr;157(4):788–798.e2. doi:https://doi.org/10.1016/j.ajo.2014.01.001.
- Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510. doi:https://doi.org/10.1016/j.jtos.2017.05.011.
- Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Investig Ophthalmol Vis Sci. 2004;45(12):4302–4311. doi:https://doi.org/10.1167/iovs.04-0299.
- Galletti JG, Gabelloni ML, Morande PE, et al. Benzalkonium chloride breaks down conjunctival immunological tolerance in a murine model. Mucosal Immunol. 2013;6(1):24–34. doi:https://doi.org/10.1038/mi.2012.44.
- Swamy M, Jamora C, Havran WHA. Epithelial decision-makers : in search of the “epimmunome”. Nat Immunol. 2010;11:656–665.
- Guzmán M, Sabbione F, Gabelloni ML, et al. Restoring conjunctival tolerance by topical nuclear factor–κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice. Investig Ophthalmol Vis Sci. 2014;55(9):6116–6126. doi:https://doi.org/10.1167/iovs.14-14075.
- Leonardi A, Doan S, Fauquert JL, et al. Diagnostic tools in ocular allergy. Allergy Eur J Allergy Clin Immunol. 2017;72(10):1485–1498. doi:https://doi.org/10.1111/all.13178.
- Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574. doi:https://doi.org/10.1016/j.jtos.2017.05.001.
- Leonardi A, Borghesan F, Scalora T, Modugno RL, Bonaldo A. Office-based ocular procedures for the allergist. Curr Opin Allergy Clin Immunol. 2019;19(5):488–494. doi:https://doi.org/10.1097/ACI.0000000000000563.
- O’Brien RM. Skin prick testing and in vitro assays for allergic sensitivity. Aust Prescr. 2002;25(4):91–93. doi:https://doi.org/10.18773/austprescr.2002.077.
- Wachholz PA, Dearman RJ, Kimber I. Detection of allergen-specific IgE antibody responses. J Immunotoxicol. 2005;1:189–199.
- Roy N, Levanon S, Asbell PA. Potential biomarkers for allergic conjunctival diseases. Eye Contact Lens. 2020;46:S109–S121. doi:https://doi.org/10.1097/ICL.0000000000000688.
- Leonardi A. Allergy and allergic mediators in tears. Exp Eye Res. 2013;117:106–117. doi:https://doi.org/10.1016/j.exer.2013.07.019.
- Shoji J. Ocular allergy test and biomarkers on the ocular surface: clinical test for evaluating the ocular surface condition in allergic conjunctival diseases. Allergol Int. 2020;69(4):496–504. doi:https://doi.org/10.1016/j.alit.2020.05.003.
- Leonardi A, Secchi AG. Vernal keratoconjunctivitis. Int Ophthalmol Clin. 2003;43(1):41–58. doi:https://doi.org/10.1097/00004397-200343010-00007.
- Leonardi A. Vernal keratoconjunctivitis: pathogenesis and treatment. Prog Retin Eye Res. 2002;21(3):319–339. doi:https://doi.org/10.1016/S1350-9462(02)00006-X.
- Fernando P, Marziali E, Chlubek M, et al. Pulsed oral corticosteroids for the treatment of vernal and atopic keratoconjunctivitis: a management plan. Eye (Lond). July 2020. https://doi.org/10.1038/s41433-020-1062-2
- Secchi AG, Tognon MS, Leonardi A. Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis. Am J Ophthalmol. 1990;110(6):641–645. doi:https://doi.org/10.1016/S0002-9394(14)77061-8.
- Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25(2):171–175. doi:https://doi.org/10.1097/01.ico.0000176611.88579.0a.
- Yazu H, Shimizu E, Aketa N, et al. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis. Ann Allergy Asthma Immunol Off Publ Am Co.ll Allergy Asthma Immunol. 2019;122(4):387–392.e1. doi:https://doi.org/10.1016/j.anai.2019.01.004.
- Leonardi A, Silva D, Perez Formigo D, et al. Management of ocular allergy. Allergy Eur J Allergy Clin Immunol. 2019;74(9):1611–1630. doi:https://doi.org/10.1111/all.13786.
- Takamura E, Uchio E, Ebihara N, et al. Japanese guidelines for allergic conjunctival diseases 2017. Allergol Int. 2017;66(2):220–229. doi:https://doi.org/10.1016/j.alit.2016.12.004.
- Gkalpakiotis S, Arenberger P, Skalicka P, Arenbergerova M. Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis. J Eur Acad Dermatol Venereol. 2020;34(6):e281–e283. doi:https://doi.org/10.1111/jdv.16278.
- Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628. doi:https://doi.org/10.1016/j.jtos.2017.05.006.
- Iaccheri B, Torroni G, Cagini C, et al. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine. Eye. 2017;31(5):788–794. doi:https://doi.org/10.1038/eye.2017.3.